Janus Kinase Inhibitor Use Among People With Inflammatory Disease in Australia

Claire T. Deakin, Michael O. Falster, Geoffrey O. Littlejohn, Peter Youssef, David Liew, Nicole L. Pratt, Sallie‐Anne Pearson

Open source

DOI
10.1002/pds.70503
Published
2026-10-30
Container
Pharmacoepidemiology and Drug Safety
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/pds.70503,
  title = {Janus Kinase Inhibitor Use Among People With Inflammatory Disease in Australia},
  author = {Claire T. Deakin and Michael O. Falster and Geoffrey O. Littlejohn and Peter Youssef and David Liew and Nicole L. Pratt and Sallie‐Anne Pearson},
  year = {2026},
  journal = {Pharmacoepidemiology and Drug Safety},
  doi = {10.1002/pds.70503},
  url = {https://doi.org/10.1002/pds.70503}
}

RIS

TY  - JOUR
TI  - Janus Kinase Inhibitor Use Among People With Inflammatory Disease in Australia
AU  - Claire T. Deakin
AU  - Michael O. Falster
AU  - Geoffrey O. Littlejohn
AU  - Peter Youssef
AU  - David Liew
AU  - Nicole L. Pratt
AU  - Sallie‐Anne Pearson
PY  - 2026
JO  - Pharmacoepidemiology and Drug Safety
DO  - 10.1002/pds.70503
UR  - https://doi.org/10.1002/pds.70503
ER  - 

APA

Deakin, C. T., Falster, M. O., Littlejohn, G. O., Youssef, P., Liew, D., Pratt, N. L., & Pearson, S. (2026). Janus Kinase Inhibitor Use Among People With Inflammatory Disease in Australia. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70503

Source records